Skip to main content

Clover Health Investments, Corp (CLOV) Stock Analysis

Recovery setup

SellModerate Confidence

Healthcare · Healthcare Plans

Sell if holding. Engine safety override at $3.59: Quality below floor (2.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.1/10. Specifically: Below-average business quality; Negative price momentum.

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for... Read more

$3.59+1.3% A.UpsideScore 5.1/10#6 of 11 Healthcare Plans
QualityF-score4 / 9FCF yield4.07%
Stop $3.33Target $3.63(resistance)A.R:R -2.2:1
Analyst target$2.82-21.5%3 analysts
$3.63our TP
$3.59price
$2.82mean
$3

Sell if holding. Engine safety override at $3.59: Quality below floor (2.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.1/10. Specifically: Below-average business quality; Negative price momentum. Chart setup: Death cross but MACD improving, RSI 79. Score 5.1/10, moderate confidence.

Passes 6/9 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity 76d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: aggressive.

Recent Developments — Clover Health Investments, Corp

Generated 2026-05-20T21:06:21Z.

Thesis

Rewards
No bull case signals
Risks
Target reached (-33.2% upside)
Quality below floor (2.0 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)35.0
Mkt Cap$1.8B
EV/EBITDA-28.9
Profit Mgn-2.6%
ROE-16.9%
Rev Growth62.0%
Beta2.45
DividendNone
Rating analysts10

Quality Signals

Piotroski F4/9

Options Flow

P/C1.09bearish
IV76%elevated
Max Pain$1-86.1% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

3 floor-breakers·1 ceiling hit

Unprofitable operations — net margin -2.6%. Quality floor flags this regardless of sector context.static

Roe
0.0
Roa
0.0
Gross Margin
0.0
Net Margin
0.0
Operating Margin
1.5
Piotroski F
4.4
Moat
4.8
Current Ratio
5.0
No competitive moatQuality concerns

Volatile — 6.0% daily ATR makes tight stops impractical. Position-size conservatively.static

Volatility
0.0
Implied Vol
0.6
Beta
1.8
Max Pain Risk
3.0
Days To Cover
3.5
Short Interest
5.3
Put Call
6.1
High IV: 76%Above max pain $0

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Support Resistance
0.9
Bollinger
1.4
52w Position
8.3
GatesMomentum 4.0<4.5A.R:R -2.2=NEGATIVEDeath cross (50MA < 200MA)Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 76d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
79 · Overbought
20D MA 50D MA 200D MADEATH CROSSSupport $2.35Resistance $3.70

Price Targets

$3
$4
A.Upside+1.1%
A.R:R-2.2:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-33.2% upside)
! Quality below floor (2.0 < 4.0)
! Momentum score 4.0/10 — below 4.5 minimum

Earnings

B
M
M
M
1/4 beats
Next Earnings2026-08-04 (76d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CLOV stock a buy right now?

Sell if holding. Engine safety override at $3.59: Quality below floor (2.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.1/10. Specifically: Below-average business quality; Negative price momentum. Chart setup: Death cross but MACD improving, RSI 79. Prior stop was $3.33. Score 5.1/10, moderate confidence.

What is the CLOV stock price target?

Take-profit target: $3.63 (+1.3% upside). Prior stop was $3.33. Stop-loss: $3.33.

What are the risks of investing in CLOV?

Target reached (-33.2% upside); Quality below floor (2.0 < 4.0).

Is CLOV overvalued or undervalued?

Clover Health Investments, Corp trades at a P/E of N/A (forward 35.0). TrendMatrix value score: 7.1/10. Verdict: Sell.

What do analysts say about CLOV?

10 analysts cover CLOV with a consensus score of 3.8/5. Average price target: $3.

What does Clover Health Investments, Corp do?Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred...

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.

Related stocks: PGNY (Progyny, Inc.) · OSCR (Oscar Health, Inc.) · ALHC (Alignment Healthcare, Inc.) · MOH (Molina Healthcare Inc)